Skip to content
Loading…
The World Health Organization launched the first clinical trial on Tuesday to test whether an antiviral drug can prevent infection in people exposed to the Bundibugyo strain of Ebola in the Democratic Republic of Congo, as the outbreak continues to outpace response efforts and…
To respect copyright, we link to the source rather than republishing the full text. Read the complete article on France 24.